PTI reported. Wearing a mask is a must even after vaccination.To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said on Tuesday.
Manufacturing scale up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore, the company said in a statement.Meanwhile, India became the fastest country to administer 13 crore COVID vaccine doses, the Union Health Ministry said today.